151 related articles for article (PubMed ID: 35758473)
1. The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials.
Gkiourtzis Ν; Kalopitas G; Vadarlis A; Bakaloudi DR; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):e31-e37. PubMed ID: 35758473
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
[TBL] [Abstract][Full Text] [Related]
3. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
[TBL] [Abstract][Full Text] [Related]
4. Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis.
Dionysopoulos G; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis N; Karanika E; Tsekitsidi E; Chourdakis M
Crit Rev Food Sci Nutr; 2023; 63(27):8545-8553. PubMed ID: 35400251
[TBL] [Abstract][Full Text] [Related]
5. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
6. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis.
Yang Y; Yang L; Wu J; Hu J; Wan M; Bie J; Li J; Pan D; Sun G; Yang C
Clin Nutr; 2024 Jun; 43(6):1224-1239. PubMed ID: 38643738
[TBL] [Abstract][Full Text] [Related]
7. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW.
Chaves FGB; Oliveira GF; Ribeiro JP; Serafim JV; Cordeiro LFM; Alvares MA; Cecchi MT; Vasquez MC; Souza TBD; Rullo VEV
Rev Paul Pediatr; 2021; 39():e2019226. PubMed ID: 32876312
[TBL] [Abstract][Full Text] [Related]
8. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
9. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Yang R; Shang J; Zhou Y; Liu W; Tian Y; Shang H
Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1401-1409. PubMed ID: 34877910
[TBL] [Abstract][Full Text] [Related]
10. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
14. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Johnston BC; Goldenberg JZ; Vandvik PO; Sun X; Guyatt GH
Cochrane Database Syst Rev; 2011 Nov; (11):CD004827. PubMed ID: 22071814
[TBL] [Abstract][Full Text] [Related]
16. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
17. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.
Ebrahimi-Mousavi S; Alavian SM; Sohrabpour AA; Dashti F; Djafarian K; Esmaillzadeh A
BMC Gastroenterol; 2022 Mar; 22(1):102. PubMed ID: 35255811
[TBL] [Abstract][Full Text] [Related]
18. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.
Famouri F; Shariat Z; Hashemipour M; Keikha M; Kelishadi R
J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):413-417. PubMed ID: 28230607
[TBL] [Abstract][Full Text] [Related]
19. The clinical effect of probiotics on patients with non-alcoholic fatty liver disease: a meta-analysis.
Wang Y; Wang Y; Sun J
Bioengineered; 2022; 13(7-12):14960-14973. PubMed ID: 37105767
[TBL] [Abstract][Full Text] [Related]
20. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
